81
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Banxia Xiexin Decoction Inhibits the Expression of PD-L1 Through Multi-Target and Multi-Pathway Regulation of Major Oncogenes in Gastric Cancer

, , , &
Pages 3297-3307 | Published online: 19 May 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ling Chen, Li-Quan Ren, Zhong Liu, Xin Liu, Han Tu & Xu-Ying Huang. (2021) Bio-informatics and in Vitro Experiments Reveal the Mechanism of Schisandrin A Against MDA-MB-231 cells. Bioengineered 12:1, pages 7678-7693.
Read now

Articles from other publishers (4)

Xiaojun Dai, Yanwei Yu, Chen Zou, Bo Pan, Haibo Wang, Shanshan Wang, Xiaojuan Wang, Chenghai Wang, Dongmei Liu & Yanqing Liu. (2023) Traditional Banxia Xiexin decoction inhibits invasion, metastasis, and epithelial mesenchymal transition in gastric cancer by reducing lncRNA TUC338 expression. Heliyon 9:11, pages e21064.
Crossref
Zehua Zhou, Rui AnLisha YouKun LiangXinhong Wang. (2023) Banxia Xiexin decoction: A review on phytochemical, pharmacological, clinical and pharmacokinetic investigations. Medicine 102:35, pages e34891.
Crossref
Liping Han, Ting Li, Yingying Wang, Weizi Lai, Hengpu Zhou, Zhuangwei Niu, Jie Su, Guiyuan Lv, Guangji Zhang, Jianli Gao, Jianbo Huang & Zhaohuan Lou. (2023) Weierning, a Chinese patent medicine, improves chronic atrophic gastritis with intestinal metaplasia. Journal of Ethnopharmacology 309, pages 116345.
Crossref
Kyung-Soo Chun, Do-Hee Kim, Pawan Kumar Raut & Young-Joon Surh. (2022) Anticancer natural products targeting immune checkpoint protein network. Seminars in Cancer Biology 86, pages 1008-1032.
Crossref